Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39137

DNAJB4 Knockout Hela Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Adenocarcinoma

DNAJB4 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population targeting the DNAJB4 co-chaperone gene. This model disrupts DNAJB4 function in the widely used HeLa cervical adenocarcinoma cell line, enabling focused study of Hsp70-mediated protein folding, trafficking, and degradation processes. DNAJB4 interacts with HSPA1A/HSPA8 and BAG family proteins and is regulated by HSF1 under stress conditions. The knockout cells are suitable for proteostasis investigations, protein aggregation assays, and chaperone activity measurements, providing a tool for cancer and neurodegeneration research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HeLa

    Sex of Donor

    Female

    Age

    31 years

    Gene Name

    DNAJB4

    Gene Identifier

    NCBI Gene ID 11080

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAJB4 Knockout HeLa Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout cell population designed for loss-of-function analysis of the DNAJB4 gene. This product provides a targeted gene disruption model in HeLa cells, enabling detailed investigation of DNAJB4-dependent cellular processes. The polyclonal knockout format ensures a heterogeneous population carrying diverse CRISPR/Cas9-mediated disruptions, reflecting a broad range of editing events without selection for single-cell clonal expansion. Researchers can employ this model to dissect the specific contributions of DNAJB4 to protein homeostasis and stress-responsive pathways in a well-characterized human epithelial cell background.

HeLa cells serve as the host line, an immortalized epithelial line derived from a cervical adenocarcinoma. These cells are robust and easy to manipulate, making them a mainstay in biomedical research, particularly for studies of cancer biology, signal transduction, and stress responses. Their rapid proliferation and well-documented molecular landscape facilitate reproducible experimental setups. The epithelial origin is especially relevant for investigations of protein quality control mechanisms that are frequently dysregulated in carcinomas, and the endogenous expression of heat shock pathway components in HeLa cells provides a relevant context for probing DNAJB4 function.

DNAJB4 functions as a co-chaperone that stimulates the ATPase activity of Hsp70 family members, including HSPA1A (Hsp70) and HSPA8 (Hsc70), thereby accelerating the cycle of substrate binding and release. This activity is essential for the folding, trafficking, and degradation of misfolded and aggregation-prone client proteins. The protein is integrated into the heat shock response and the unfolded protein response, with expression regulated by the transcription factor HSF1 upon exposure to stressors such as heat shock and oxidative stress. At the molecular level, DNAJB4 interacts with BAG family co-chaperones and the E3 ubiquitin ligase STUB1, forming complexes that channel irreparable substrates toward proteasomal clearance. Representative components of this signaling network include HSF1, HSPA1A, STUB1, and HSP90, which collectively govern proteostasis.

In the HeLa cellular environment, disruption of DNAJB4 creates a platform to interrogate the consequences of impaired Hsp70-mediated protein quality control. Without functional DNAJB4, the cell??s ability to manage misfolded protein loads under basal and stress conditions is compromised, potentially leading to increased protein aggregation and altered cell survival pathways. This model is therefore instrumental in linking chaperone dysfunction to pathological states such as cancer and neurodegeneration, where proteostatic collapse is a common feature. Researchers can monitor how loss of DNAJB4 affects the handling of endogenous aggregation-prone substrates or influences the cellular response to chemotherapeutic agents that induce proteotoxic stress.

The DNAJB4 Knockout HeLa Polyclonal Cells are suited for a wide range of experimental applications, including proteostasis studies, chaperone function assays, and protein aggregation research. Typical techniques employed include western blotting to assess changes in chaperone and client protein levels, co-immunoprecipitation to examine altered protein?Cprotein interactions within the Hsp70 machinery, and ATPase activity assays to quantify co-chaperone function directly. Protein aggregation assays and HSF1 activity reporter assays further enable modeling of stress response dynamics, while immunofluorescence can visualize localization changes of key effectors. For additional details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)